학술논문
CHK1 inhibitor SRA737 is active in PARP inhibitor resistant and CCNE1 amplified ovarian cancer
Document Type
Article
Author
Xu, Haineng; Gitto, Sarah B.; Ho, Gwo-Yaw; Medvedev, Sergey; Shield-Artin, Kristy; Kim, Hyoung; Beard, Sally; Kinose, Yasuto; Wang, Xiaolei; Barker, Holly E.; Ratnayake, Gayanie; Hwang, Wei-Ting; Hansen, Ryan J.; Strouse, Bryan; Milutinovic, Snezana; Hassig, Christian; Wakefield, Matthew J.; Vandenberg, Cassandra J.; Scott, Clare L.; Simpkins, Fiona
Source
In iScience 19 July 2024 27(7)
Subject
Language
ISSN
2589-0042